This paper is a systematic literature review of Randomized Control Trials and Economic Evaluations focusing on symptom reduction in adults ages 18 and older treated by five branded Proton Pump Inhibitors for diagnosed Gastroesophageal Reflux Disease in North America and Europe. As the disease affects roughly 20-30% of people living in western countries regardless of age, an understanding of how to provide the best care using Proton Pump Inhibitors with consideration of clinical and economic outcomes is of vital importance. The purpose of this study is to compare the mean differences in intragastric pH values from day one to day five of the five proton pump inhibitors to answer which has the greatest efficacy. This paper will also focus on t...
Medical therapy of gastroesophageal reflux disease (GERD) is based on the use of proton pump inhibit...
Background. Many investigators have proposed an association between gastro-oesophageal reflux diseas...
Protonic pump inhibitors (PPIs) are the most prescribed drugs for acute and maintenance therapy of g...
This paper is a systematic literature review of Randomized Control Trials and Economic Evaluations f...
Background: Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that result...
Background: Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that result...
Aim. The study was conducted to estimate the clinical and pharmacoeconomic efficiency of proton pump...
Objective: Although some patients may prefer using a particular kind of proton pump inhibitor in gas...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Aim of review. To present literature data on efficacy and safety of esomeprazole for the treatment o...
Objective: The aim of this paper was to develop a guideline on the over-the-counter management of ga...
Proton pump inhibitors (PPIs) are antisecretory agents that are widely used in the short- and long-t...
Gastroesophageal reflux disease (GERD) is one of the most prevalent conditions worldwide and is conv...
AbstractBackground: Proton pump inhibitors (PPIs) cost the French health care system >€1 billion in ...
AIM: To test the Genval recommendations and the usefulness of a short trial of proton pump inhibito...
Medical therapy of gastroesophageal reflux disease (GERD) is based on the use of proton pump inhibit...
Background. Many investigators have proposed an association between gastro-oesophageal reflux diseas...
Protonic pump inhibitors (PPIs) are the most prescribed drugs for acute and maintenance therapy of g...
This paper is a systematic literature review of Randomized Control Trials and Economic Evaluations f...
Background: Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that result...
Background: Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that result...
Aim. The study was conducted to estimate the clinical and pharmacoeconomic efficiency of proton pump...
Objective: Although some patients may prefer using a particular kind of proton pump inhibitor in gas...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Aim of review. To present literature data on efficacy and safety of esomeprazole for the treatment o...
Objective: The aim of this paper was to develop a guideline on the over-the-counter management of ga...
Proton pump inhibitors (PPIs) are antisecretory agents that are widely used in the short- and long-t...
Gastroesophageal reflux disease (GERD) is one of the most prevalent conditions worldwide and is conv...
AbstractBackground: Proton pump inhibitors (PPIs) cost the French health care system >€1 billion in ...
AIM: To test the Genval recommendations and the usefulness of a short trial of proton pump inhibito...
Medical therapy of gastroesophageal reflux disease (GERD) is based on the use of proton pump inhibit...
Background. Many investigators have proposed an association between gastro-oesophageal reflux diseas...
Protonic pump inhibitors (PPIs) are the most prescribed drugs for acute and maintenance therapy of g...